BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 19635042)

  • 1. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network.
    Wiederkehr D; Berenson K; Casciano R; Stern L; Makenbaeva D; Mozaffari E; Lamerato L; Corbelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2317-25. PubMed ID: 19635042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.
    Wiederkehr D; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Corbelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2327-34. PubMed ID: 19635046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome.
    Ho PM; Fihn SD; Wang L; Bryson CL; Lowy E; Maynard C; Magid DJ; Peterson ED; Jesse RL; Rumsfeld JS
    Am Heart J; 2007 Nov; 154(5):846-51. PubMed ID: 17967588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system.
    Ho PM; Tsai TT; Wang TY; Shetterly SM; Clarke CL; Go AS; Sedrakyan A; Rumsfeld JS; Peterson ED; Magid DJ
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):303-8. PubMed ID: 20354221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Ergelen M; Uyarel H; Osmonov D; Ayhan E; Akkaya E; Soylu O; Orhan AL; Sayar N; Bozbay M; Turer A; Yildirim E; Yekeler I
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):33-41. PubMed ID: 19736213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
    Brar SS; Kim J; Brar SK; Zadegan R; Ree M; Liu IL; Mansukhani P; Aharonian V; Hyett R; Shen AY
    J Am Coll Cardiol; 2008 Jun; 51(23):2220-7. PubMed ID: 18534267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
    Casella G; Ottani F; Pavesi PC; Sangiorgio P; Rubboli A; Galvani M; Fontanelli A; Bracchetti D
    Ital Heart J; 2003 Oct; 4(10):677-84. PubMed ID: 14664280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care.
    Ho PM; Tsai TT; Maddox TM; Powers JD; Carroll NM; Jackevicius C; Go AS; Margolis KL; DeFor TA; Rumsfeld JS; Magid DJ
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):261-6. PubMed ID: 20407117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel.
    Chastek B; Riedel AA; Wygant G; Hauch O
    Curr Med Res Opin; 2009 Dec; 25(12):2845-52. PubMed ID: 19831706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.
    Geisler T; Langer H; Wydymus M; Göhring K; Zürn C; Bigalke B; Stellos K; May AE; Gawaz M
    Eur Heart J; 2006 Oct; 27(20):2420-5. PubMed ID: 17005534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study.
    Bonde L; Sorensen R; Fosbøl EL; Abildstrøm SZ; Hansen PR; Kober L; Schramm TK; Bretler DM; Weeke P; Olesen J; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2010 Mar; 55(13):1300-7. PubMed ID: 20338489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database.
    Petersen JL; Barron JJ; Hammill BG; Cziraky MJ; Anstrom KJ; Wahl PM; Eisenstein EL; Krucoff MW; Califf RM; Schulman KA; Curtis LH
    Am Heart J; 2010 Mar; 159(3):462-470.e1. PubMed ID: 20211310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes after a change in prescription policy for clopidogrel.
    Jackevicius CA; Tu JV; Demers V; Melo M; Cox J; Rinfret S; Kalavrouziotis D; Johansen H; Behlouli H; Newman A; Pilote L
    N Engl J Med; 2008 Oct; 359(17):1802-10. PubMed ID: 18946065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.
    Banerjee S; Varghese C; Samuel J; Weideman RA; Little BB; Kelly KC; Rao SV; Reilly RF; Brilakis ES
    Am J Cardiol; 2008 Nov; 102(9):1159-62. PubMed ID: 18940284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.
    Brar SS; ten Berg J; Marcucci R; Price MJ; Valgimigli M; Kim HS; Patti G; Breet NJ; DiSciascio G; Cuisset T; Dangas G
    J Am Coll Cardiol; 2011 Nov; 58(19):1945-54. PubMed ID: 22032704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.